{"id":233755,"date":"2023-01-31T08:25:00","date_gmt":"2023-01-31T07:25:00","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=233755"},"modified":"2023-01-31T09:45:08","modified_gmt":"2023-01-31T08:45:08","slug":"formacio-risc-trombotic-pacient-oncologic-farmacia","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/","title":{"rendered":"Formaci\u00f3 ‘Risc tromb\u00f2tic en el pacient oncol\u00f2gic’"},"content":{"rendered":"\n

Dimarts, 7 de febrer, de 15.00 a 16.00 h. Els socis de la FEFAC tenen un 25% de descompte! Demana el teu codi a la FEFAC abans de fer la inscripci\u00f3!<\/strong><\/h2>\n\n\n\n

Els pacients amb c\u00e0nce<\/strong>r tenen molt m\u00e9s risc tromb\u00f2tic<\/strong> que els pacients sense c\u00e0ncer.<\/p>\n\n\n\n

En aquesta sessi\u00f3 participar\u00e0 el doctor Andr\u00e9s J. Mu\u00f1oz<\/strong>, professor associat del servei d’Oncologia M\u00e8dica de l’Hospital General Universitari Gregorio Mara\u00f1\u00f3n, tamb\u00e9 coordinador de la secci\u00f3 C\u00e0ncer i trombosi de la Societat Espanyola d’Oncologia M\u00e8dica. I Montserrat Abanades<\/strong>, cofundadora i partner d’Hydroskin Oncology.<\/strong><\/p>\n\n\n\n

La formaci\u00f3 forma part del programa de formaci\u00f3 continuada d’Hydroskin Oncology Academy dirigida a farm\u00e0cies comunit\u00e0ries especialitzades en oncologia<\/strong> i compta amb l’aval cient\u00edfic de Fundaci\u00f3 ECO <\/a><\/span><\/em><\/strong>(Fundaci\u00f3 per a l’Excel\u00b7l\u00e8ncia i la Qualitat de l’Oncologia).<\/p>\n\n\n\n

Segons el doctor Andres J. Mu\u00f1oz, \u00e9s molt important que el farmac\u00e8utic comunitari estigui format en aquestes complicacions, “ja que \u00e9s el primer sanitari que acudeix el pacient”.<\/p>\n\n\n\n

Amb motiu del dia internacional del c\u00e0ncer infantil el pr\u00f2xim dia 15 de febrer<\/strong>, els beneficis d’aquesta sessi\u00f3 es donaran per a la recerca en el c\u00e0ncer infantil. Concretament, tots els beneficis d’aquesta formaci\u00f3 es destinaran a la recerca del c\u00e0ncer infantil a l’Hospital Sant Joan de D\u00e9u Barcelona.<\/strong><\/p>\n\n\n\n

Inscripcions a la sessi\u00f3 sobre risc tromb\u00f2tic en el pacient oncol\u00f2gic<\/h3>\n\n\n\n

La sessi\u00f3 \u00e9s online i t\u00e9 un cost de 50 euros.<\/strong> Si ets soci tens un 25% de descompte. Demana el teu codi de descompte a la FEFAC <\/strong>(fefac@fefac.cat – 93 323 24 22) abans de realitzar la teva inscripci\u00f3<\/a><\/em><\/span><\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Dimarts, 7 de febrer, de 15.00 a 16.00 h. Els socis de la FEFAC tenen un 25% de descompte! Demana el teu codi a la FEFAC abans de fer la inscripci\u00f3!<\/p>\n","protected":false},"author":2313,"featured_media":233756,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2066,10,11,12,13,14,15,116,19,251],"tags":[1127,1128,1501,2411],"class_list":["post-233755","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-categoria-actualitat","category-empresarials","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-formacio","category-professio","category-reflexions-de-junta","tag-farmacia","tag-farmaceutic","tag-oncologia","tag-pacient-oncologic"],"yoast_head":"\nFormaci\u00f3 'Risc tromb\u00f2tic en el pacient oncol\u00f2gic'<\/title>\n<meta name=\"description\" content=\"Dimarts, 7 de febrer, de 15.00 a 16.00 h formaci\u00f3 en risc tromb\u00f2tic en pacient oncol\u00f2gic. Els socis de la FEFAC tenen un 25% de descompte!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Formaci\u00f3 'Risc tromb\u00f2tic en el pacient oncol\u00f2gic'\" \/>\n<meta property=\"og:description\" content=\"Dimarts, 7 de febrer, de 15.00 a 16.00 h formaci\u00f3 en risc tromb\u00f2tic en pacient oncol\u00f2gic. Els socis de la FEFAC tenen un 25% de descompte!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T07:25:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-31T08:45:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/01\/formacion-oncologia.png\" \/>\n\t<meta property=\"og:image:width\" content=\"480\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"lclavijo@afb.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lclavijo@afb.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/\"},\"author\":{\"name\":\"lclavijo@afb.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"headline\":\"Formaci\u00f3 ‘Risc tromb\u00f2tic en el pacient oncol\u00f2gic’\",\"datePublished\":\"2023-01-31T07:25:00+00:00\",\"dateModified\":\"2023-01-31T08:45:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/\"},\"wordCount\":301,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/formacion-oncologia.png\",\"keywords\":[\"farm\u00e0cia\",\"farmac\u00e8utic\",\"oncologia\",\"pacient oncol\u00f2gic\"],\"articleSection\":[\"Actualitat\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Formaci\u00f3\",\"Professi\u00f3\",\"Reflexions de Junta\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/\",\"name\":\"Formaci\u00f3 'Risc tromb\u00f2tic en el pacient oncol\u00f2gic'\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/formacion-oncologia.png\",\"datePublished\":\"2023-01-31T07:25:00+00:00\",\"dateModified\":\"2023-01-31T08:45:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"description\":\"Dimarts, 7 de febrer, de 15.00 a 16.00 h formaci\u00f3 en risc tromb\u00f2tic en pacient oncol\u00f2gic. Els socis de la FEFAC tenen un 25% de descompte!\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/formacion-oncologia.png\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/formacion-oncologia.png\",\"width\":480,\"height\":480},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/formacio-risc-trombotic-pacient-oncologic-farmacia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Formaci\u00f3 ‘Risc tromb\u00f2tic en el pacient oncol\u00f2gic’\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d'Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\",\"name\":\"lclavijo@afb.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/laura-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Formaci\u00f3 'Risc tromb\u00f2tic en el pacient oncol\u00f2gic'","description":"Dimarts, 7 de febrer, de 15.00 a 16.00 h formaci\u00f3 en risc tromb\u00f2tic en pacient oncol\u00f2gic. Els socis de la FEFAC tenen un 25% de descompte!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/","og_locale":"ca_ES","og_type":"article","og_title":"Formaci\u00f3 'Risc tromb\u00f2tic en el pacient oncol\u00f2gic'","og_description":"Dimarts, 7 de febrer, de 15.00 a 16.00 h formaci\u00f3 en risc tromb\u00f2tic en pacient oncol\u00f2gic. Els socis de la FEFAC tenen un 25% de descompte!","og_url":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/","og_site_name":"FEFAC","article_published_time":"2023-01-31T07:25:00+00:00","article_modified_time":"2023-01-31T08:45:08+00:00","og_image":[{"width":480,"height":480,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/01\/formacion-oncologia.png","type":"image\/png"}],"author":"lclavijo@afb.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lclavijo@afb.cat","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/"},"author":{"name":"lclavijo@afb.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"headline":"Formaci\u00f3 ‘Risc tromb\u00f2tic en el pacient oncol\u00f2gic’","datePublished":"2023-01-31T07:25:00+00:00","dateModified":"2023-01-31T08:45:08+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/"},"wordCount":301,"commentCount":0,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/01\/formacion-oncologia.png","keywords":["farm\u00e0cia","farmac\u00e8utic","oncologia","pacient oncol\u00f2gic"],"articleSection":["Actualitat","Empresarials","FEFAC","AFB","AFET","AFELL","AGFE","Formaci\u00f3","Professi\u00f3","Reflexions de Junta"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/","url":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/","name":"Formaci\u00f3 'Risc tromb\u00f2tic en el pacient oncol\u00f2gic'","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/01\/formacion-oncologia.png","datePublished":"2023-01-31T07:25:00+00:00","dateModified":"2023-01-31T08:45:08+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"description":"Dimarts, 7 de febrer, de 15.00 a 16.00 h formaci\u00f3 en risc tromb\u00f2tic en pacient oncol\u00f2gic. Els socis de la FEFAC tenen un 25% de descompte!","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/01\/formacion-oncologia.png","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2023\/01\/formacion-oncologia.png","width":480,"height":480},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/formacio-risc-trombotic-pacient-oncologic-farmacia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Formaci\u00f3 ‘Risc tromb\u00f2tic en el pacient oncol\u00f2gic’"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d'Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744","name":"lclavijo@afb.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/laura-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/233755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/2313"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=233755"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/233755\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/233756"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=233755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=233755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=233755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}